Last week, readers were most interested in a story about Roche and BARDA teaming up to develop diagnostic tests for traumatic brain injuries.

Last week, readers were most interested in a story about Roche and BARDA teaming up to develop diagnostic tests for traumatic brain injuries.

NowDx's First to Know Syphilis Test received FDA authorization in August, making it the first over-the-counter syphilis test to be authorized by the agency.

The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.

The company aims to streamline its own lab operations while also enabling distribution of its Alzheimer's tests to outside ...

The IHC companion diagnostic test determines CLDN18 protein expression and may help identify patients who are eligible for treatment with Vyloy.

The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.

The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.

The agreement's goal is to bring a blood-based test to market to stratify patients with traumatic brain injuries.

CyPath Lung is a laboratory-developed assay that uses self-collected sputum samples treated with a fluorescent compound that preferentially binds to cancer cells and cancer-related cells, San ...